Overview
FLGT market data
Price History
FLGT price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for FLGT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Reported Earlier, Fulgent Genetic Announced It Presented Updated Data In The Head And Neck Cancer Track During The American Society Of Clinical Oncology 2026 Annual Meeting Rapid Oral Abstract Session In Hall D1 At Mccormick Place In ChicagoBenzinga · Jun 2, 2026, 8:14 AM
8-K filing — Fulgent Genetics, Inc. (FLGT)SEC EDGAR · Jun 1, 2026, 11:07 PM
Fulgent Genetics' FID-007 Plus Cetuximab Shows 60% Response Rate And 7.2-Month Median PFS In Phase 2 Head And Neck Cancer Study With Favorable Safety ProfileBenzinga · May 21, 2026, 9:15 PM